Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiotech Gwth Regulatory News (BIOG)

Share Price Information for Biotech Gwth (BIOG)

Share Price is delayed by 15 minutes
Get Live Data
1,448.00    44.00 (3.13%)
Bid:
1,436.00
Ask:
1,454.00
Spread: 18.00 (1.253%)
Market Cap: £278.85m
BIOG Live PriceLast checked at - London Stock Exchange

Intraday Biotech Gwth Share Chart

Total Voting Rights

2 Jan 2024 09:32

The Biotech Growth Trust Plc - Total Voting Rights

The Biotech Growth Trust Plc - Total Voting Rights

PR Newswire

LONDON, United Kingdom, January 02

The Biotech Growth Trust PLC

2 January 2024

The Biotech Growth Trust PLC

Voting Rights and Capital

In accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, The Biotech Growth Trust PLC (the "Company") announces the following:

As at 31 December 2023, the Company capital consists of ordinary shares of 25p with each ordinary share holding one voting right. The total number of ordinary shares in issue is 34,555,600. The Company has no ordinary shares in Treasury.

Therefore, the total number of voting rights in the Company is 34,555,600.

The above figure (34,555,600) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in the Company or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

- END -

Frostrow Capital LLP

Company Secretary

Tel: 0203 709 8734



Date   Source Headline
1st May 20261:37 pmPRNNet Asset Value(s)
1st May 20269:48 amPRNTotal Voting Rights
30th Apr 20261:16 pmPRNNet Asset Value(s)
29th Apr 20262:31 pmPRNNet Asset Value(s)
28th Apr 20261:12 pmPRNNet Asset Value(s)
27th Apr 20261:08 pmPRNNet Asset Value(s)
24th Apr 20265:40 pmPRNTransaction in Own Shares
24th Apr 20261:51 pmPRNNet Asset Value(s)
23rd Apr 20261:10 pmPRNNet Asset Value(s)
22nd Apr 20263:05 pmPRNNet Asset Value(s)
21st Apr 202611:45 amPRNNet Asset Value(s)
20th Apr 20262:28 pmPRNNet Asset Value(s)
17th Apr 20265:23 pmPRNTransaction in Own Shares
17th Apr 20262:38 pmPRNNet Asset Value(s)
16th Apr 20261:21 pmPRNNet Asset Value(s)
15th Apr 202612:59 pmPRNNet Asset Value(s)
14th Apr 202612:46 pmPRNNet Asset Value(s)
13th Apr 20261:44 pmPRNNet Asset Value(s)
13th Apr 202610:31 amPRNMonthly Fact Sheet as at 31 March 2026
10th Apr 20265:23 pmPRNTransaction in Own Shares
10th Apr 20262:36 pmPRNNet Asset Value(s)
9th Apr 20261:22 pmPRNNet Asset Value(s)
8th Apr 20263:05 pmPRNNet Asset Value(s)
7th Apr 20261:08 pmPRNNet Asset Value(s)
2nd Apr 20265:01 pmPRNTransaction in Own Shares
2nd Apr 20262:23 pmPRNNet Asset Value(s)
1st Apr 20264:16 pmPRNNet Asset Value(s)
1st Apr 20269:59 amPRNTotal Voting Rights
1st Apr 20267:00 amPRNBiogen, Inc. to acquire BIOG portfolio company, Apellis Pharmaceuticals, Inc.
31st Mar 202612:42 pmPRNNet Asset Value(s)
30th Mar 202612:43 pmPRNNet Asset Value(s)
27th Mar 20265:16 pmPRNTransaction in Own Shares
27th Mar 20261:35 pmPRNNet Asset Value(s)
26th Mar 20261:08 pmPRNNet Asset Value(s)
25th Mar 20262:08 pmPRNNet Asset Value(s)
24th Mar 202612:34 pmPRNNet Asset Value(s)
23rd Mar 20263:13 pmPRNNet Asset Value(s)
20th Mar 20265:18 pmPRNTransaction in Own Shares
20th Mar 20261:55 pmPRNNet Asset Value(s)
19th Mar 202612:38 pmPRNNet Asset Value(s)
18th Mar 20261:35 pmPRNNet Asset Value(s)
17th Mar 202612:41 pmPRNNet Asset Value(s)
16th Mar 20262:15 pmPRNNet Asset Value(s)
13th Mar 20265:19 pmRNSTransaction in Own Shares
13th Mar 20265:19 pmPRNTransaction in Own Shares
13th Mar 20262:54 pmPRNNet Asset Value(s)
12th Mar 20261:16 pmPRNNet Asset Value(s)
12th Mar 20267:00 amRNS-RKepler Trust Intelligence: New Research
11th Mar 20262:08 pmRNSMonthly Fact Sheet as at 28 February 2026
11th Mar 20262:08 pmPRNMonthly Fact Sheet as at 28 February 2026

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.